Investigative Ophthalmology & Visual Science, Vol 38, 824-833, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels

P Choudhury, W Chen and RC Hunt
Department of Microbiology and Immunology, University of South Carolina School of Medicine, Columbia 29208, USA.

PURPOSE: In an in vitro model of the later contractile stages of proliferative vitreoretinopathy, interleukin-1 beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) stimulate the contraction of collagen gels by retinal pigment epithelial (RPE) cells. This contraction occurs after a lag period and appears not to be a direct effect of the cytokines but is mediated by another factor produced in the presence of the two cytokines. The nature of this factor has been investigated. METHODS: Human RPE cells were seeded onto collagen gels in the presence of IL-1 beta and TGF-beta. After 24 hours, the conditioned medium was removed and added to new collagen gels seeded with RPE cells, and the diameter of the collagen gels was measured after various intervals. The ability of the conditioned medium to effect contraction was determined after various treatments, including size fractionation, heating, trypsin digestion, and binding to heparin- Sepharose. The involvement of platelet-derived growth factor (PDGF) as a stimulator of contraction was tested with neutralizing antibodies and by polymerase chain reaction analyses of specific mRNAs. RESULTS: IL-1 beta and TGF-beta cause RPE cells to contract after a delay of up to 24 hours, whereas conditioned medium from cytokine-treated cells results in immediate contraction in a manner similar to that of serum. The factor in the conditioned medium causing immediate contraction was found to be heat-stable, trypsin-sensitive, and resistant to extremes of pH. It has a size of between 30 and 50 kDa and binds heparin. The factor in conditioned medium from cytokine-treated cells does not act in the presence of C-kinase inhibitors or cycloheximide, suggesting that signaling is mediated by way of protein kinase C and new protein synthesis. Stimulation of contraction by conditioned medium is inhibited by anti-PDGF antibodies, and contraction is stimulated by human PDGF. CONCLUSIONS: Contraction in the presence of cytokines is mediated by the production of PDGF or a PDGF-like molecule. This factor could have implications in the pathogenesis of proliferative vitreoretinopathy.

This article has been cited by other articles:

				H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2335 - 2342. [Abstract] [Full Text] [PDF]

				I. Milenkovic, M. Weick, P. Wiedemann, A. Reichenbach, and A. Bringmann P2Y Receptor-Mediated Stimulation of Muller Glial Cell DNA Synthesis: Dependence on EGF and PDGF Receptor Transactivation Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1211 - 1220. [Abstract] [Full Text] [PDF]

				Y. Ikuno and A. Kazlauskas An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411. [Abstract] [Full Text] [PDF]

				T. Mio, X. Liu, M. L. Toews, Y. Adachi, D. J. Romberger, J. R. Spurzem, and S. I. Rennard Bradykinin augments fibroblast-mediated contraction of released collagen gels Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L164 - L171. [Abstract] [Full Text] [PDF]

				I A El-Ghrably, H. S Dua, G. M Orr, D. Fischer, and P. J Tighe Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy Br. J. Ophthalmol., April 1, 2001; 85(4): 461 - 470. [Abstract] [Full Text]

				A. Ando, M. Ueda, M. Uyama, Y. Masu, and S. Ito Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor Br. J. Ophthalmol., November 1, 2000; 84(11): 1306 - 1311. [Abstract] [Full Text] [PDF]

				Y. Ikuno, F.-L. Leong, and A. Kazlauskas Attenuation of Experimental Proliferative Vitreoretinopathy by Inhibiting the Platelet-Derived Growth Factor Receptor Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3107 - 3116. [Abstract] [Full Text]

				T. Udono, K. Takahashi, M. Nakayama, O. Murakami, Y. K. Durlu, M. Tamai, and S. Shibahara Adrenomedullin in Cultured Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1962 - 1970. [Abstract] [Full Text]

				L. Carrington, D. McLeod, and M. Boulton IL-10 and Antibodies to TGF-{beta}2 and PDGF Inhibit RPE-Mediated Retinal Contraction Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1210 - 1216. [Abstract] [Full Text]